Researchers have been excited about the medication , a novel dual agonist showing promising results in clinical trials for size loss . It acts by targeting two hormones : GLP-1 and GIP, these, when https://larissamtxr067461.bluxeblog.com/73160155/a-new-possibility-for-weight-management